BTX161 is a Thalidomide analogue. BTX161 is a potent CKIalpha degrader. In human AML cells, BTX161 mediates the CKIalpha degradation better than Lenalidomide as well as activates DNA damage response (DDR) and p53, and also stabilizes the p53 antagonist MDM2[1].
Molecular Weight:
272.3
CAS Number:
[2052301-24-1]
Formula:
C15H16N2O3
Target:
Others|||Casein Kinase
T60478
* VAT and and shipping costs not included. Errors and price changes excepted
